Collegium Pharmaceutical, Inc. (COLL) NASDAQ

Currency In USD

AD

Collegium Pharmaceutical, Inc.

Address

100 Technology Center Drive

Stoughton, MA 02072

United States of America (the)

Phone

781 713 3699

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

423

First IPO Date

May 07, 2015

Key Executives

NameTitlePayYear Born
Vikram KarnaniPresident, Chief Executive Officer & Director1.72M1975
David DieterExecutive Vice President, General Counsel & Corporate Secretary782,2831964
Thomas Smith FAAFPExecutive Vice President & Chief Medical Officer825,6941961
Colleen TupperExecutive Vice President & Chief Financial Officer1.03M1976
Jessica CotroneSenior Vice President of Corporate Communications & Corporate Affairs0N/A
Dean J. PatrasChief People Officer0N/A
Ian KarpHead of Investor Relations0N/A
Scott SudduthEVP & Head of Technical Operations0N/A
Jane GonnermanExecutive Vice President of Strategy & Corporate Development0N/A
AD

Description

Collegium Pharmaceutical, Inc. (COLL) is a specialized pharmaceutical firm dedicated to the development and marketing of medications for pain management. Its diverse product lineup features significant therapies aimed at addressing various pain conditions. A prominent offering is Xtampza ER, an extended-release, oral formulation of oxycodone, specifically engineered with properties to deter abuse. This particular drug is prescribed for patients experiencing severe, persistent pain that necessitates daily, continuous, long-term opioid therapy. The company's portfolio also encompasses Nucynta ER and Nucynta IR, which are extended-release and immediate-release versions of tapentadol, respectively. Founded in 2002, the enterprise initially operated under the name Collegium Pharmaceuticals, Inc., before officially adopting its current identity as Collegium Pharmaceutical, Inc. in October 2003. The company's corporate headquarters are situated in Stoughton, Massachusetts.

AD